CIK 0001842952
- Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863738787
- Phone
- +1 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +270,000 | 270,000 | ||
| 2025-06-06 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +20,000 | $0.58 | $12K | 29,000 |
| 2025-02-13 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +349,900 | 349,900 | ||
| 2024-03-21 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +153,515 | 153,515 | ||
| 2023-02-13 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +151,505 | 151,505 | ||
| 2022-12-09 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +6,000 | $0.85 | $5K | 9,000 |
| 2022-02-25 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +107,870 | 107,870 | ||
| 2021-10-22 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +3,000 | $5.00 | $15K | 3,000 |
Page 1 of 1 · 8 trades